Get the app
public
ios_share
OncoPharm
chevron_right
Data Dive Into NK-1 Antagonists & Carboplatin
Nov 7, 2019
17:02
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
ASCO's updated 2017 antiemetic guidelines recommend NK-1 antagonists to prevent CINV with standard Q 3 week carboplatin (i.e. AUC 5-6), but how good are the data to support that? We dive into the supporting data.
